Literature DB >> 22262355

Modification of the ferret model for pneumonia from seasonal human influenza A virus infection.

J M A van den Brand1, K J Stittelaar, L M E Leijten, G van Amerongen, J H Simon, A D M E Osterhaus, T Kuiken.   

Abstract

The primary complication of seasonal influenza in humans is viral pneumonia. A conventional animal model--intranasal inoculation of ferrets with 10(6) median tissue culture infectious dose of virus--results in disease that is neither consistent nor comparable with severe viral pneumonia in humans. Therefore, the authors modified the experimental procedures by increasing the median tissue culture infectious dose to 10(9) and by inoculating via the intratracheal route, testing these procedures with H1N1 strains (A/Bilthoven/3075/1978 and A/Netherlands/26/2007) and H3N2 strains (A/Bilthoven/16190/1968 and A/Netherlands/177/2008) of seasonal influenza virus. The ferrets of all groups (n = 3 per virus strain) had clinical signs, increased body temperature, virus excretion from day 1, loss of body weight, and increased relative lung weight at 4 days postinoculation. All ferrets had severe pulmonary consolidation, and histologic examination revealed moderate to severe necrotizing bronchointerstitial pneumonia with severe edema, necrosis of alveolar epithelium, inflammatory infiltrates in alveolar septa and lumina, epithelial regeneration, and perivascular and peribronchiolar inflammatory infiltrates. The lesions were associated with the presence of influenza virus antigen in respiratory epithelium by immunohistochemistry. Although all 4 virus strains caused pulmonary lesions of comparable severity, virus isolation in the lungs, trachea, nasal concha, and tonsils showed higher mean virus titers in the H1/07 and H3/68 groups than in the H1/78 and H3/08 groups. In conclusion, the above H1N1 and H3N2 strains cause severe pneumonia in ferrets by use of the modified experimental procedures and provide a good model for pneumonia caused by seasonal influenza A virus infection in humans.

Entities:  

Mesh:

Year:  2012        PMID: 22262355     DOI: 10.1177/0300985811429812

Source DB:  PubMed          Journal:  Vet Pathol        ISSN: 0300-9858            Impact factor:   2.221


  17 in total

1.  Lower Respiratory Tract Infection of the Ferret by 2009 H1N1 Pandemic Influenza A Virus Triggers Biphasic, Systemic, and Local Recruitment of Neutrophils.

Authors:  Jeremy V Camp; Ulas Bagci; Yong-Kyu Chu; Brendan Squier; Mostafa Fraig; Silvia M Uriarte; Haixun Guo; Daniel J Mollura; Colleen B Jonsson
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

2.  Increased Protein Degradation Improves Influenza Virus Nucleoprotein-Specific CD8+ T Cell Activation In Vitro but Not in C57BL/6 Mice.

Authors:  Arwen F Altenburg; Carolien E van de Sandt; Stella E van Trierum; Heidi L M De Gruyter; Peter R W A van Run; Ron A M Fouchier; Kenny Roose; Xavier Saelens; Asisa Volz; Gerd Sutter; Rory D de Vries; Guus F Rimmelzwaan
Journal:  J Virol       Date:  2016-10-28       Impact factor: 5.103

3.  Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia.

Authors:  Mart Toots; Jeong-Joong Yoon; Robert M Cox; Michael Hart; Zachary M Sticher; Negar Makhsous; Roland Plesker; Alec H Barrena; Prabhakar G Reddy; Deborah G Mitchell; Ryan C Shean; Gregory R Bluemling; Alexander A Kolykhalov; Alexander L Greninger; Michael G Natchus; George R Painter; Richard K Plemper
Journal:  Sci Transl Med       Date:  2019-10-23       Impact factor: 17.956

4.  Severity of clinical disease and pathology in ferrets experimentally infected with influenza viruses is influenced by inoculum volume.

Authors:  Ian N Moore; Elaine W Lamirande; Myeisha Paskel; Danielle Donahue; Heather Kenney; Jing Qin; Kanta Subbarao
Journal:  J Virol       Date:  2014-09-03       Impact factor: 5.103

5.  Characterization of the Localized Immune Response in the Respiratory Tract of Ferrets following Infection with Influenza A and B Viruses.

Authors:  Louise A Carolan; Steve Rockman; Kathryn Borg; Teagan Guarnaccia; Patrick Reading; Jennifer Mosse; Anne Kelso; Ian Barr; Karen L Laurie
Journal:  J Virol       Date:  2015-12-30       Impact factor: 5.103

6.  Intranasal H5N1 vaccines, adjuvanted with chitosan derivatives, protect ferrets against highly pathogenic influenza intranasal and intratracheal challenge.

Authors:  Alex J Mann; Nicolas Noulin; Andrew Catchpole; Koert J Stittelaar; Leon de Waal; Edwin J B Veldhuis Kroeze; Michael Hinchcliffe; Alan Smith; Emanuele Montomoli; Simona Piccirella; Albert D M E Osterhaus; Alastair Knight; John S Oxford; Giulia Lapini; Rebecca Cox; Rob Lambkin-Williams
Journal:  PLoS One       Date:  2014-05-21       Impact factor: 3.240

7.  Host-specific exposure and fatal neurologic disease in wild raptors from highly pathogenic avian influenza virus H5N1 during the 2006 outbreak in Germany.

Authors:  Judith Ma van den Brand; Oliver Krone; Peter U Wolf; Marco W G van de Bildt; Geert van Amerongen; Albert D M E Osterhaus; Thijs Kuiken
Journal:  Vet Res       Date:  2015-03-05       Impact factor: 3.683

8.  Comparison of temporal and spatial dynamics of seasonal H3N2, pandemic H1N1 and highly pathogenic avian influenza H5N1 virus infections in ferrets.

Authors:  Judith M A van den Brand; Koert J Stittelaar; Geert van Amerongen; Leslie Reperant; Leon de Waal; Albert D M E Osterhaus; Thijs Kuiken
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

9.  Activation of coagulation and tissue fibrin deposition in experimental influenza in ferrets.

Authors:  Marco Goeijenbier; Eric C M van Gorp; Judith M A Van den Brand; Koert Stittelaar; Kamran Bakhtiari; Joris J T H Roelofs; Geert van Amerongen; Thijs Kuiken; Byron E E Martina; Joost C M Meijers; Albert D M E Osterhaus
Journal:  BMC Microbiol       Date:  2014-05-30       Impact factor: 3.605

10.  Accelerating Influenza Research: Vaccines, Antivirals, Immunomodulators and Monoclonal Antibodies. The Manufacture of a New Wild-Type H3N2 Virus for the Human Viral Challenge Model.

Authors:  Daniel J Fullen; Nicolas Noulin; Andrew Catchpole; Hosnieh Fathi; Edward J Murray; Alex Mann; Kingsley Eze; Ganesh Balaratnam; Daryl W Borley; Anthony Gilbert; Rob Lambkin-Williams
Journal:  PLoS One       Date:  2016-01-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.